Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as offers genetic testing options, including preimplantation genetic testing (PGT); and IVF consultancy services. In addition, the company operates hospital, in-house pharmacy; and 7 hubs (IVF centers) and 28 spokes. The company was founded in 2009 and is based in headquartered in New Delhi, India.
| Current Price | ₹124.60 |
|---|---|
| Market Cap | ₹0 Cr |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Services > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Services; Medical Laboratory Services; Fertility Clinics |
| P/E Ratio | 31.8 |
| 52-Week Range | ₹69.18 – ₹136.52 |
1. Healthcare Facilities & Services-100%
Gaudium IVF and Women Health Limited is trading at ₹124.60, with a market capitalisation of ₹0 Cr.
Gaudium IVF and Women Health Limited operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Services > Health Care; Health Care Equipment and Services; Health Care Providers and Services; Health Care Services; Medical Laboratory Services; Fertility Clinics).
Gaudium IVF and Women Health Limited has a P/E of 31.8.